Fig. 1From: Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in AustriaTreatment duration of atezolizumab and nab-paclitaxel, previous and subsequent treatment lines. * ongoing treatment, ** death, *** best supportive care, **** loss to follow-upBack to article page